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Objective:To investigate the effect of the interaction between gestational diabetes mellitus
(GDM) and maternal body mass index (BMI) on the individual neonatal growth parameters.
Design: Retrospective cohort study.
Setting: A tertiary maternity service in Sydney, Australia, between 2005 and 2009.
Population: A cohort of 8859 women.
Methods: Generalized linear models.
Mainoutcomemeasures:Neonatal growth parameters, represented by z -scores for infant
birth weight (BW), birth length (BL), and head circumference (HC) in GDM and non-GDM
groups.
Results: Only GDM alone had an independent and positive effect on BL (p=0.02) but not
on BW or HC. In addition, in pregnancies complicated with GDM, the association between
maternal weight and BW was significantly stronger (p<0.001). In combination, GDM and
maternal BMI significantly affected z -score differences between BW and BL (p<0.001), in
that underweight mothers had babies that were lighter relative to their length and inversely
obese mothers had babies that were heavier relative to their length.
Conclusion: GDM independently influences BL and increases the association between
maternal BMI and BW. In accordance with the hypothesis of the fetal origins of health and
disease, the pronounced effects of GDM on fetal growth patterns demonstrated in this
study are likely to influence long-term health outcomes in children.
Keywords: birth weight, birth length, head circumference, gestational diabetes mellitus, maternal BMI
INTRODUCTION
Fetal growth is determined by a complex interaction between
genetic factors and the in utero environment (1). Changes in the
in utero metabolic environment can be caused by both gestational
diabetes mellitus (GDM) and maternal weight.
Effects on the fetus including those that effect growth are not
only associated with short-term complications for the neonate but
are also associated with health outcomes in later life. For example,
the Dutch famine study demonstrated a clear link between fetal
growth and a range of diseases, including cardiovascular disorders
(2). This concept has been coined “The Developmental Origins of
Health and Disease (DOHaD)” and was previously summarized
under the Barker Hypothesis (3, 4).
A well established and important in utero determinant of
birth weight (BW) is GDM (5). In this condition, insulin resis-
tance and failure of β-cell compensatory mechanisms causes
increased levels of maternal glucose and lipids. The elevated
substrates are transported across the placenta overexposing the
developing fetus to nutrients, causing an increase in fetal growth
(6). GDM affects approximately 5–10% of pregnancies in Western
nations (7).
Separate to GDM, maternal obesity may also be characterized
by insulin resistance and elevated lipids, allowing excess nutri-
ents to be transferred across the placenta to the fetus contribut-
ing to fetal growth (1). Maternal obesity has been described to
have similar effect on BW as GDM (8, 9). Approximately one-
third of pregnancies are affected by maternal obesity, and in the
female Australian population 2011–2012, approximately 56% were
classified as overweight or obese (1, 10).
Apart from BW, fetal growth can also be determined by birth
length (BL) and head circumference (HC). To be able to describe
growth in more detail, it is also important to acknowledge the
relationship of these parameters to each other as a measure of fetal
growth.
Therefore, the aim of this study was to investigate the effect
of the interaction between GDM and maternal body mass index
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(BMI) on individual neonatal growth parameters and their
relationship to each other.
MATERIALS AND METHODS
This is a retrospective cohort study of deliveries from a tertiary
maternity service in Metropolitan Sydney, New South Wales, Aus-
tralia, occurring between 2005 and 2009. Women were identified
using the hospital’s obstetric database. The database is updated
and maintained during and after pregnancy, and contributes to
statewide data collection. The database identified 18,304 preg-
nancies, of which all live-born and singleton pregnancies with
gestational age greater than 24 weeks were eligible for inclusion
in the study (Figure 1). However, cases were excluded if the data
were incomplete for maternal and neonatal anthropometric mea-
surements or contained data entry errors (n= 9235). Mothers
with pre-existing diabetes were further excluded from the study
(n= 41).
Maternal characteristics extracted from the database included
weight and height measured at the booking visit, age, parity,
smoking status, and obstetric complications including GDM and
pre-eclampsia. Maternal BMI, calculated as kg/m2, were divided
into six BMI ranges according to the WHO-criteria: under-
weight (<18.5 kg/m2), normal weight (18.5–24.9 kg/m2), over-
weight (25–29.9 kg/m2), obese class I (30–34.9 kg/m2), obese class
II (35–39.9 kg/m2), and obese class III (≥40 kg/m2) (11). Mater-
nal smoking was self-reported and included smoking at any time
during pregnancy.
All pregnant women attending the antenatal clinic were offered
screening for GDM, which was done at 24–28 weeks of gesta-
tion. Depending on the medical or family history, a 50 g glucose
challenge test (GCT) or a 75 g 2 h oral glucose tolerance test
(OGTT) was conducted. Women were considered high risk for
GDM if the 1-h GCT was >7.8 mmol/L with the diagnosis being
confirmed by subsequent 2 h OGTT. GDM was diagnosed based
upon contemporaneous Australasian Diabetes in Pregnancy Soci-
ety (ADIPS) criteria; fasting glucose during OGTT≥ 5.5 mmol/L
or 2-h glucose was ≥8.0 mmol/L (12).
Neonatal variables extracted from the database included ges-
tational age at birth, BW, BL, and HC. Gestational age, in weeks,
was estimated from the time of the last menstrual period (LMP),
and was confirmed by ultrasonography. If there was a greater than
10-day difference between the estimated age by LMP and the esti-
mated age on second trimester ultrasonography, the age calculated
by ultrasonography was used.
z-scores, adjusted for gestational age, were calculated for BW,
BL, and HC without customizing for maternal characteristics (13).
STUDIED OUTCOMES
The outcomes studied were neonatal growth variables, represented
by gestational age adjusted z-scores for infant BW, BL, and HC.
To exclude biologically unrealistic values, the outcome variables
were further restricted; infants were excluded from the analy-
ses if any of the z-scores were >3 or <−3 standard deviations
from the expected mean (n= 169). This was applied to avoid out-
liers in documentation or potential other pathologies either not
or inaccurately listed in the database.
To obtain the neonatal growth proportionality, the difference
between the different z-scores was calculated: 1: HC minus BW
(HC−BW); 2: BW minus BL (BW−BL); and 3: HC minus BL
(HC−BL). For example, a baby might have a BW z-score of +1
(+1 SD from its expected mean), but a HC of −1 (−1 SD from its
expected mean), which results in a difference of 2 between the two
outcome variables, which would be a surrogate for an asymmetric
growth pattern. A perfect symmetric growth pattern would result
in a difference of 0.
STATISTICS
Descriptive statistics are reported as mean± SD and median
and interquartile range. Maternal characteristics and pregnancy
FIGURE 1 | Flow chart of the inclusion of pregnancies in the study.
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outcomes were compared between GDM and non-GDM women
using a Students t -test for normally distributed continuous
data, a Mann-Whitney U -test for skewed continuous data or a
chi-squared test for categorical data.
Generalized linear models were used to examine the effect of
GDM (yes/no) on the studied outcomes. The models were adjusted
for maternal age, maternal BMI (categorical), parity, smoking
(yes/no), maternal pre-eclampsia and hypertension, gestational
age, and infant gender. Additionally, an interaction term between
GDM and maternal BMI was investigated in each of the outcome
models. The adjusted means in each GDM group from these
models were plotted over the maternal BMI categories.
Table 1 | Maternal characteristics and pregnancy outcomes in GDM
and non-GDM women.
Characteristics GDM (n=498) Non-GDM
(n=8361)
p value
Maternal age (years) 31.6±5.2 28.6±5.3 <0.001
Maternal BMI (kg/m2) 32.0 [24.3–35.0] 24.8 [21.5–29.7] <0.001
Parity 1.0 [1.0–2.0] 1.0 [1.0–2.0] 0.034
Smoking (%) 99 (19.9) 2208 (26.4) 0.002
Hypertension (%) 40 (8) 418 (5) 0.004
Pre-eclampsia (%) 13 (2.6) 163 (2) 0.4
Gestational age (weeks) 39.0 [38.2–39.5] 39.5 [38.6–40.4] <0.001
Birth weight (g) 3384±532 3455±521 0.003
Birth length (cm) 51.0 [49.0–53.0] 51.0 [49.5–53.0] 0.5
Head circumference (cm) 34.5 [33.5–35.5] 34.5 [33.5–35.5] 0.9
BW z -score 0.29±1.1 0.09±1.0 <0.001
BL z -score 0.18±1.0 −0.02±0.94 <0.001
HC z -score 0.12±0.89 −0.04±0.86 <0.001
Values are shown as mean±SD, median [Q1–Q3] or n(%).
cm, centimeter.
SAS Version 9.3 software (SAS Institute Inc., Cary, NC, USA)
was used for all statistical analyses. A p-value of<0.05 was consid-
ered statistically significant. No adjustment was made for multiple
comparisons.
ETHICS
The study was approved by the Local Human Research Ethics
Committee of the Nepean Blue Mountains Local Health District
on 18 March 2013 (HREC no. 10/16).
RESULTS
DEMOGRAPHICS
The study included 8859 women, of whom 498 (5.6%) patients
had GDM. Maternal characteristics and pregnancy outcomes for
GDM and non-GDM women are shown in Table 1.
In pregnancies complicated with GDM, mothers were older and
had higher average BMI. They were also less likely to smoke. Exam-
ining the z-scores, adjusted for gestational age, there were signifi-
cant differences for BW,BL,and HC between the two groups,where
GDM women gave birth to babies that were heavier, longer, and
had greater HC compared to babies born to non-GDM women.
Table 2 summarizes birth parameters for all BMI groups.
THE INDEPENDENT EFFECT OF GESTATIONAL DIABETES ON GROWTH
Examining the independent effect of GDM on the neonatal growth
variables, i.e., z-scores for BW, BL, and HC, models adjusted for
maternal age, maternal BMI, parity, smoking status, hypertension,
pre-eclampsia, gestational age, and infant gender, were used. The
results show that GDM only had an independent effect on BL z-
score (p= 0.02). Excluding GDM, there is an independent effect
of BMI on z-scores for BW, BL, and HC (p< 0.001).
THE INTERACTION EFFECT BETWEEN GDM AND MATERNAL BMI
The interaction effect between GDM and maternal BMI on the
neonatal growth variables was examined. Figure 2 compares the
association between increasing maternal BMI and BW z-score in
women with and without GDM after adjusting for all confounding
Table 2 | Birth parameters according to BMI categories.
BMI categoriesa p value
1 2 3 4 5 6
Total BW z -score −0.36 −0.03 0.18 0.27 0.41 0.50 <0.001
BL z -score −0.24 −0.08 0.03 0.10 0.17 0.20 <0.001
HC z -score −0.34 −0.15 0.00 0.12 0.26 0.39 <0.001
GDM BW z -score −0.83 −0.12 0.26 0.46 0.55 1.03 <0.001
BL z -score −0.05 −0.09 0.26 0.20 0.29 0.54 <0.01
HC z -score −0.46 −0.14 0.04 0.19 0.33 0.69 <0.001
No GDM BW z -score −0.35 −0.03 0.18 0.25 0.39 0.43 <0.001
BL z -score −0.25 −0.08 0.02 0.09 0.15 0.16 <0.001
HC z -score −0.34 −0.15 0.00 0.12 0.25 0.35 <0.001
z-scores reported in means.
BW, birth weight; BL, birth length; HC, head circumference.
aBMI category 1: <18.5 kg/m2; 2: 18.5–24.9 kg/m2; 3: 25–29.9 kg/m2; 4: 30–34.9 kg/m2; 5: 35–39.9 kg/m2; 6: ≥40 kg/m2.
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FIGURE 2 |The association between increasing maternal BMI and BW
z-score in babies of GDM and non-GDM women, adjusted for all
confounding factors. Interaction GDM×maternal BMI (p<0.001).
GDM , non-GDM .
factors. The increase in BW with increasing maternal BMI is
more pronounced in pregnancies with GDM than in non-GDM
pregnancies (p< 0.001).
There was no interaction effect between maternal BMI and
GDM on BL z-scores (p= 0.19) and HC z-scores (p= 0.27).
EFFECT OF GDM ON INTRA-INDIVIDUAL LENGTH ANDWEIGHT
Z -SCORES
As we have described an independent effect of GDM on length
z-scores and a combined effect of GDM and maternal BMI on
weight z-score, we examined the effect of GDM on the relationship
between weight and length z-scores (Figure 3). In GDM women
with BMI< 18.5, the growth asymmetry is enhanced with babies
having a mean difference of almost 0.74 between their BW and
BL z-scores. The interaction effect of maternal BMI and GDM on




This retrospective study has confirmed that the association
between maternal weight and BW is more pronounced in preg-
nancies complicated with GDM. We have also found that GDM
together with maternal BMI affects the neonatal growth patterns,
specifically the relationship between BW and BL. Lean GDM
women gave birth to babies with less weight compared to their
length. Conversely, obese GDM women gave birth to babies with
greater weight compared to their length. Since the interaction
between maternal BMI and GDM did not have an effect on the
HC z-score or the BL z-score, it is proposed that the variation in
BW, in relation to maternal BMI, contributes to the asymmetry
FIGURE 3 |The association between increasing maternal BMI and the
mean differences between BW and BL z-scores in GDM and non-GDM
women. Interaction GDM×maternal BMI (p<0.01). GDM ,
non-GDM .
among babies born to GDM women. In summary, the interac-
tion between maternal weight and GDM does not seem to affect
skeletal growth, only fetal weight.
STRENGTHS AND LIMITATIONS
The strength of our study is that this study has systematically
compared the symmetry between BW, BL, and HC, between con-
trols and pregnancies affected by GDM in relation to increasing
maternal BMI.
Limitations to this study are its retrospective nature and the
unavailability of measures of maternal blood glucose values, which
have been shown to correlate to fetal and/or neonatal growth
patterns (14). In addition, the effect of treatment modality on
different growth parameters and growth proportion would be
interesting to investigate. Furthermore, a potential confounding
factor is that women with GDM were usually delivered electively at
38 weeks, and hence the natural progression of fetal proportions in
these women beyond this gestational age could not be ascertained.
Another area to consider is that we used booking weight (BMI) in
our study. Since weight gain during pregnancy has been found to
affect BW, it is possible that weight gain/loss in pregnancy might
have affected our results (15). Unfortunately, our data collection
system does not capture these parameters.
INTERPRETATION
The effect of GDM on BW has been demonstrated in previous
studies (7, 16). In addition, the HAPO study found a strong
and continuous correlation between maternal glucose levels and
increased BW (5). Although our results showed that GDM did
not have a significant independent effect on BW, we found that
GDM did enhance the effect of maternal BMI on BW confirming
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previous observations (17, 18). Makgoba et al. investigated the
interaction between GDM and maternal BMI on BW in white,
black, and South Asian women. They found that the enhancing
effect of GDM on the association between maternal BMI and BW
differed between the racial groups, suggesting that part of the inter-
action effect between GDM and maternal BMI can be attributed to
genetic factors (17). The vast majority of the cohort in this study
was of Caucasian origin.
This interaction effect cannot completely be explained by
genetics. Women who develop GDM show resistance to the action
of insulin to stimulate glucose disposal and to suppress production
of glucose and fatty acids, resulting in increased maternal plasma
glucose levels (7). The exposure to increased maternal glucose
supply stimulates fetal pancreatic insulin production, leading to
accelerated fetal growth (19). However, circulating levels of other
nutrients, such as triglycerides (TG) and free fatty acids (FFA), are
also increased in GDM and may also contribute to fetal growth (1,
6, 20). In GDM, other alterations affecting fetal growth have been
found, including increased placental weights, which could increase
placental nutrient transfer, thereby increasing fetal nutrient sup-
ply (21). Other alterations include altered levels of adipokines
correlated to BW (20, 22).
Maternal obesity, in the absence of GDM, has been found to
have a strong independent relationship with BW and the patho-
physiology may have similarities with GDM (8). Adipose tissue was
originally considered to be a storage site for TG. However, adipose
tissue is metabolically active with multiple endocrine and immune
functions, with the potential to produce disturbances in insulin
signaling pathways resulting in increased insulin resistance with
increasing weight (19). Maternal obesity is also characterized by
dyslipidaemia, which, together with insulin resistance and failure
of β-cell compensatory mechanisms, leads to increased metabolic
fuels allowing excess nutrients to be transferred across the placenta
to the fetus (1). Larger placentas are also more likely to occur in
obese women, with altered levels of adipokines, which may also be
associated with fetal growth (1, 23).
Gestational diabetes and obesity have similar metabolic and
structural alterations and may affect fetal growth in similar ways.
When combining maternal weight and GDM, we found that the
two variables together have an even more pronounced effect on
BW than either variable alone.
When examining the interaction effect between GDM and
maternal weight, we found that lean women affected with GDM
gave birth to babies with less weight in relation to both the HC and
BL compared to controls. We hypothesize that the insulin treat-
ment given to lean women with GDM may have a greater effect
on growth potential, and in comparison to obese women treated
with insulin, lean women might not have been able to compen-
sate for low blood glucose values with higher lipid values, which
have also been found to affect fetal growth (20). In this context,
treatment with insulin would be interesting to analyze in future
studies.
Previous studies have investigated the independent effect of
GDM on other growth parameters, such as HC and BL. How-
ever, these studies have either examined growth parameters during
pregnancy only or analyzed the odds ratio of LGA in length among
babies born to women with GDM (16, 24).
We found that the interaction between GDM and maternal
BMI did not have a positive effect on BL or HC. Neither did
GDM alone affect the HC. Nevertheless, GDM had an independent
effect on BL.
CONCLUSION
Gestational diabetes increases the association between maternal
weight and neonatal BW. In addition, GDM together with mater-
nal BMI affects the neonatal growth patterns more than either
variable alone. We hypothesize the variation in BW, in relation to
maternal BMI, contributes to the asymmetry among babies born
to GDM women. How GDM in combination with maternal BMI
and their effect on fetal growth patterns affect the well-being of
the child later in life will need to be addressed in future studies.
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